TriLink BioTechnologies, Inc.

TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a licensing agreement with Biofortuna Ltd. (Biofortuna) for use of CleanAmp™ dNTPs in Biofortuna’s freeze dried in vitro diagnostic PCR kits.

TriLink BioTechnologies (TriLink), announced that it is sponsoring SAY San Diego’s “Take Me Out to the Ballgame”, a series of San Diego Padre games in the month of August to benefit San Diego families in need.

The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.

TriLink BioTechnologies, Inc. (TriLink), a key manufacturer of high quality oligonucleotides and nucleoside triphosphates, announced the launch of its new website and OligoBuilder® online oligonucleotide ordering system.

TriLink BioTechnologies, Inc. (TriLink) announced that it has signed an agreement with ETS Laboratories (ETS) to supply CleanAmp™ dNTPs for use in their Scorpions™ Wine Spoilage Detection System.

TriLink BioTechnologies, has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.

TriLink has signed a distribution agreement with Nacalai USA, Inc., a San Diego based manufacturing and marketing company, for the distribution of TriLink’s modified nucleic acid products in Japan, Singapore, South Korea and Taiwan.